Important Statement: Since our basket trial for
Post# of 145680
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
Since our basket trial for all solid tumor cancers has been initiated, we are currently screening a prostate cancer patient, and if continued positive clinical results are forthcoming from this patient, we are hopeful that this will clear the path for CytoDyn to file for Breakthrough Therapy designation for all solid tumor cancers. Our mechanism of action is not only focused on the inhibition of metastasis of solid tumor cancers, but also targets the tumor itself through macrophages, angiogenesis and T-reg.”
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)